发明授权
US08877190B2 Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
有权
A＆bgr 构象异构选择性抗A＆bgr; 球聚体单克隆抗体
- 专利标题： Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
- 专利标题（中）： A＆bgr 构象异构选择性抗A＆bgr; 球聚体单克隆抗体
-
申请号： US13102713申请日： 2011-05-06
-
公开(公告)号： US08877190B2公开(公告)日： 2014-11-04
- 发明人: Stefan Barghorn , Heinz Hillen , Andreas R. Striebinger , Boris Labkovsky , Ulrich Ebert , Patrick Keller
- 申请人： Stefan Barghorn , Heinz Hillen , Andreas R. Striebinger , Boris Labkovsky , Ulrich Ebert , Patrick Keller
- 申请人地址： US IL North Chicago DE Wiesbaden
- 专利权人： AbbVie Inc.,AbbVie Deutschland GmbH & Co. KG
- 当前专利权人： AbbVie Inc.,AbbVie Deutschland GmbH & Co. KG
- 当前专利权人地址： US IL North Chicago DE Wiesbaden
- 代理机构： Michael Best & Friedrich LLP
- 代理商 Lisa V. Mueller
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07K16/18
摘要：
The subject invention relates to monoclonal antibodies that may be used in the treatment and diagnosis of Alzheimer's Disease. In particular, the present invention relates to monoclonal antibodies referred to as 10F4 and 3C5 and to other monoclonal antibodies (e.g., murine, human or humanized) having similar properties thereto.